Ddavp Tablets 0.1mg. 0.2mg Tablet
PDF Leaflet Revision Date: 5 June 2002
Clinical Summary
Quick overview from the medicine insert
Indication
Management of central diabetes insipidus and primary nocturnal enuresis in children.
Dosage (summary)
0.1 mg three times daily for diabetes insipidus; 0.2 mg at bedtime for enuresis.
Onset of Action / Duration
Onset: 30 mins, Duration: 8-12 hours
Special Populations
- Elderly
- Children
Pregnancy & Breastfeeding
Safety during pregnancy and lactation not established.
Key Drug Interactions
- Tricyclic antidepressants
- SSRIs
- Chlorpromazine
- Carbamazepine
- Glibenclamide
Contraindications
- Nephrogenic diabetes insipidus
- Hypersensitivity
- Pregnancy
- Cardiac failure
- Cirrhosis
- Hypertension
Common side effects
- Headache
- Hyponatraemia
- Nausea
- Flushing
Counselling Points
- Limit fluid intake before and after administration
- Monitor for signs of hyponatraemia
- Adjust dosage based on response
Serious warnings
- Risk of water retention and hyponatraemia
- Monitor fluid intake in children
Important Disclaimer
The Ddavp Tablets 0.1mg. 0.2mg Tablet professional information leaflet below is the property of Ferring and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
